3-ft has been researched along with ubenimex in 1 studies
| Studies (3-ft) | Trials (3-ft) | Recent Studies (post-2010) (3-ft) | Studies (ubenimex) | Trials (ubenimex) | Recent Studies (post-2010) (ubenimex) |
|---|---|---|---|---|---|
| 16 | 1 | 0 | 930 | 43 | 182 |
| Protein | Taxonomy | 3-ft (IC50) | ubenimex (IC50) |
|---|---|---|---|
| Aminopeptidase B | Rattus norvegicus (Norway rat) | 6 | |
| M1 family aminopeptidase | Plasmodium falciparum FcB1/Columbia | 0.284 | |
| Cytosol aminopeptidase | Bos taurus (cattle) | 1.0005 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 6.45 | |
| Leukotriene A-4 hydrolase | Homo sapiens (human) | 1.4742 | |
| Aminopeptidase N | Homo sapiens (human) | 2.6333 | |
| Aminopeptidase N | Sus scrofa (pig) | 3.8211 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 2.7 | |
| Puromycin-sensitive aminopeptidase | Homo sapiens (human) | 3.5 | |
| Bacterial leucyl aminopeptidase | Vibrio proteolyticus | 1.0005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koshida, K; Kunimi, K; Uchibayashi, T; Yamamoto, H | 1 |
1 trial(s) available for 3-ft and ubenimex
| Article | Year |
|---|---|
Adjuvant therapy with 5-fluoro-1-(2-tetrahydrofuryl)-2,4 (1H,3H)-pyrimidinedione (UFT) and Bestatin in patients with transitional cell carcinoma of the bladder--comparison between UFT therapy alone and UFT therapy in combination with Bestatin.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Female; Humans; Isomerism; Leucine; Male; Middle Aged; Prospective Studies; Tegafur; Urinary Bladder Neoplasms | 1995 |